Jefferies Upgrades STERIS to Buy
The upgrade and target imply meaningful upside, but the signal is based on analyst judgment rather than a confirmed business event.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The upgrade and target imply meaningful upside, but the signal is based on analyst judgment rather than a confirmed business event.
What happened, with direct paths to the underlying reporting
Jefferies upgraded STERIS to Buy and set a $305 target, versus a posted price of $253.44.
Target: $305
Posted price: $253.44
Analyst firm: Jefferies
Analyst: David Windley
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.